SCOPE AI ENGAGES WITH AD AGENCIES AND NETWORKS TO OPTIMIZE GEM PLATFORM
Get Alerts SCPE Hot Sheet
Join SI Premium – FREE
These friendly collaborations are part of Scope AI's commitment to ensuring that the functionality and features of its GEM (General Enterprise Machine Learning) platform are the best market-product fit. By engaging directly with industry professionals, Scope AI is gathering critical feedback to refine and enhance GEM's capabilities, making it a more valuable tool for advertisers, brands, agencies, and Adtech service providers.
GEM, Scope AI's flagship product, is designed to revolutionize the advertising technology sector through advanced AI-driven visual recognition and neural network technology. The platform will enable users to streamline processes, maximize return on ad spend, and analyze user behavior through custom neural networks without the need for expensive and risky live campaign testing.
"Our approach is to start with the pain points of our potential users and build solutions based on those insights," said
Scope AI's commitment to innovation and user-centric development is further evidenced by its expanding development team, which is focused on incorporating feedback from these collaborations into the GEM platform. By doing so, Scope AI aims to deliver cutting-edge AI solutions that drive growth, productivity, and campaign performance in the advertising technology sector.
About Scope AI Corp.:
Scope AI Corp. is a leading technology company headquartered in
For more information please visit Scope AI Corp., [email protected], or follow along on social media.
LinkedIn: scope-ai-corp
Facebook: Scope AI Corp
Twitter: https://twitter.com/ScopeAICorp
Contact Information
(604) 416-1720
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's prospectus dated
The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Logo - https://mma.prnewswire.com/media/2414853/4733184/Scope_AI_Corp_logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/scope-ai-engages-with-ad-agencies-and-networks-to-optimize-gem-platform-302158642.html
SOURCE Scope AI Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invitation to media and analyst briefing for Ericsson Q2 2026 report
- Celea Therapeutics Announces $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
- Michelin: Disclosure of trading in own shares - July 2nd, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share